Posard Matthew L.
Reporting owner on Forms 3, 4 and 5, CIK 1543792.
Posard Matthew L. reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. CIK 1159036 | director | 1 | 2026-10-02 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. Common Stock | 2026-10-01 | S sold | -730 | $107.168 | 58,109 | Form 4 |
| HALOZYME THERAPEUTICS, INC. Common Stock | 2026-10-01 | S sold | -3,300 | $108.454 | 54,809 | Form 4 |
| HALOZYME THERAPEUTICS, INC. Common Stock | 2026-10-01 | S sold | -1,100 | $109.569 | 53,709 | Form 4 |
| HALOZYME THERAPEUTICS, INC. Common Stock | 2026-10-01 | S sold | -100 | $110.04 | 53,609 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001159036-26-000133 | HALOZYME THERAPEUTICS, INC. | 2026-10-02 |